Hexarad offers an end-to-end radiology software suite including a proprietary radiology information system (RIS), the Hexarad Edge integration engine, Hexarad Hub for urgent reporting and Hexarad Portal for auto-allocation. The company also delivers tech-enabled teleradiology services to the NHS and imaging centres across the UK and Ireland and serves customers in Saudi Arabia. Its auto-allocation tool assigns scans 90% more quickly than manual allocation and the platform has attracted over 200 radiologists to date, delivering industry-leading turnaround times and high customer satisfaction. Hexarad’s work has reduced diagnostic waiting times in NHS settings — one deployment saved 14 hours of A&E referral time a night at North West Anglia NHS Foundation. The founding team are NHS consultant radiologists (company founded in 2016) and emphasise clinically led product development. Management and investors plan to scale teleradiology services and expand the company’s software product offerings. Hexarad is an early-stage, high-growth healthcare technology company founded in 2016 by NHS consultant radiologists and led by CEO Dr Farzana Rahman. Its core product, Optirad, is a workflow management software tool that analyses and deploys a radiology department’s workforce to reduce scan reporting delays, with features including rota management, intelligent allocations, business intelligence and supply-and-demand forecasting. Optirad can operate across multiple sites and assign specialist reporting to the most appropriate radiologist. The company plans to use the funds to grow its radiology platform, support more NHS and private healthcare customers, add deeper capability and specialisation to its reporter network, and further improve its core technology. Hexarad positions its technology-driven solutions as addressing key causes of diagnostic delays. Financially, the company has completed a Series A round that now totals £4.5m.

Total raised

$18M

Funding rounds

2

Latest round

Equity

Latest activity

Aug 2024